CYNO Cynosure - Class A (MM)

WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference. Chief Financial Officer Timothy Baker will discuss Cynosure's business outlook, growth strategy and recent financial results in a presentation beginning at 2:10 p.m. ET Wednesday, October 3. The conference will be held at the Grand Hyatt New York Hotel. Investors interested in listening to the live webcast of this presentation should log on to the "Investor Relations" section of Cynosure's website, http://www.cynosure.com/, and click on the link labeled "Events." The presentation will be archived on the company's website. About Leerink Swann & Company Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, asset management, and strategic advisory services for institutional, life sciences, and high net worth clients. For the past six years, Institutional Investor has named Leerink Swann "Best of the Boutiques" in Healthcare. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community-based healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member NASD/SIPC. For more information, visit http://www.leerink.com/. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill Associates, Inc., +1-617-542-5300, Web site: http://www.cynosure.com/ http://www.leerlink.com/

Copyright